Company / Income Tax
Arcutis Biotherapeutics, Inc. Income Tax History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$1.2M
FY2025
5-year range
$0 / $3.1M
FY2021-FY2025
Trend
+81.0%
vs FY2024
Sector context
#72 of 204
Health Care
What the data says
At $1M, Arcutis Biotherapeutics, Inc.'s income tax ranks #133 of 204 in the Health Care sector. Improved from $3M to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2025.
Improved from $3M to $1M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#133 of 204 in Health CareTop 65% of 204This company $1.2M Sector average $118.7M
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, income tax increased 81.0% year-over-year.
- Ranks #72 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2023.
- Lowest income tax in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2M | +81.0% |
| FY2024 | $647.0K | -79.2% |
| FY2023 | $3.1M | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026